Omada Health (OMDA) Cost of Revenue (2024 - 2026)

Omada Health (OMDA) has 3 years of Cost of Revenue data on file, last reported at $29.4 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 27.28% year-over-year to $29.4 million; the trailing twelve-month figure through Mar 2026 stood at $95.6 million (up 32.29% YoY), and the FY2025 full-year result was $89.3 million, up 33.39% from the prior year.
• Cost of Revenue advanced to $29.4 million in Q1 2026, from $22.2 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $29.4 million in Q1 2026 to a low of $15.8 million in Q4 2024.
• A 3-year average of $21.0 million and a median of $21.6 million in 2025 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue soared 40.01% in 2025 and rose 27.28% in 2026, its largest moves.
• Tracing OMDA's Cost of Revenue over 3 years: stood at $15.8 million in 2024, then surged by 40.01% to $22.2 million in 2025, then jumped by 32.33% to $29.4 million in 2026.
• Business Quant data shows OMDA's Cost of Revenue at $29.4 million in Q1 2026, $22.2 million in Q4 2025, and $23.0 million in Q3 2025.